Medpace Holdings Inc
Open
SectorHealthcare
620.79 0.98
Overview
Share price change
24h
Min
610.22
Max
618.87
Income | -2.5M 121M |
|---|---|
Sales | 727K 707M |
P/E Sector Avg | 36.377 48.735 |
EPS | 4.25 |
Profit margin | 17.158 |
Employees | 6,500 |
EBITDA | -6.9M 148M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | -1.03% downside |
Next Earnings | 21 Oct 2026 |
|---|
Market Cap | 2.2B 17B |
|---|---|
Previous open | 619.81 |
Previous close | 620.79 |
Medpace Holdings Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Medpace Holdings Inc Forecast
Price Target
By TipRanks
-1.03% downside
12 Months Forecast
Average 612.1 USD -1.03%
High 700 USD
Low 492 USD
Based on 12 Wall Street analysts offering 12 month price targets forMedpace Holdings Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.